US 12420113
Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy
granted A61KA61K31/4725A61P
Quick answer
US patent 12420113 (Methods and apparatus for applying tumor treating fields combined with personalized ultra-fractionated stereotactic adaptive radiotherapy) held by The Board of Regents of the University of Texas System expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4725, A61P, A61P35/00